TYPE-1 GAUCHER DISEASE - MOLECULAR, BIOCHEMICAL, AND CLINICAL CHARACTERIZATION OF PATIENTS FROM NORTHERN PORTUGAL

被引:35
作者
AMARAL, O
LACERDA, L
SANTOS, R
PINTO, RA
AERTS, H
MIRANDA, MCS
机构
[1] INST GENET MED JACINTO MAGALHAES, UNIDADE ENZIMOL, PR PEDRO NUNES 74, P-4000 OPORTO, PORTUGAL
[2] UNIV AMSTERDAM, EC SLATER INST BIOCHEM RES, AMSTERDAM, NETHERLANDS
来源
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 1993年 / 49卷 / 01期
关键词
D O I
10.1006/bmmb.1993.1011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the study of 16 catholic type 1 Gaucher disease patients originating from a well-defined region in the north of Portugal where a relatively high incidence is observed. The patients were screened for mutations: 3060G → A, 5841A → G, 5976C → G, and 6433T → G, which enabled the identification of 27 of the 32 mutated alleles. Four different genotypes were identified, namely 5841G/6433C (n = 6). 5841G/5841G (n = 5), 5841G/? (n = 4). and 6433C/? (n = 1). All but one of the patients carried at least one 5841G mutated allele, making its frequency 62.5%, which is similar to that described for Ashkenazi Jewish patients. The 5841G homozygotes presented an overall milder clinical profile, whereas no clear genotype/phenotype correlation could he established for heterozygous patients. On the basis of residual glucocerebrosidase activity, no distinction could be made between 5841G homozygotes and 5841G/6433C compound heterozygotes. Patients that had at least one 5841G allele (encoding the Ser 370 mutated enzyme) all presented a cell-type-specific residual glucocerebrosidase activity as well as an increased molecular activity when measured in the presence of the physiological activators. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:97 / 107
页数:11
相关论文
共 28 条
[1]   CONDITIONS AFFECTING THE ACTIVITY OF GLUCOCEREBROSIDASE PURIFIED FROM SPLEENS OF CONTROL SUBJECTS AND PATIENTS WITH TYPE-1 GAUCHER DISEASE [J].
AERTS, JMFG ;
MIRANDA, MCS ;
BROUWERKELDER, EM ;
VANWEELY, S ;
BARRANGER, JA ;
TAGER, JM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1041 (01) :55-63
[2]   COMPARATIVE-STUDY ON GLUCOCEREBROSIDASE IN SPLEENS FROM PATIENTS WITH GAUCHER DISEASE [J].
AERTS, JMFG ;
DONKERKOOPMAN, WE ;
BRUL, S ;
VANWEELY, S ;
MIRANDA, MCS ;
BARRANGER, JA ;
TAGER, JM ;
SCHRAM, AW .
BIOCHEMICAL JOURNAL, 1990, 269 (01) :93-100
[3]   MONOCLONAL-ANTIBODIES AGAINST HUMAN BETA-GLUCOCEREBROSIDASE [J].
BARNEVELD, RA ;
TEGELAERS, FPW ;
GINNS, EI ;
VISSER, P ;
LAANEN, EA ;
BRADY, RO ;
GALJAARD, H ;
BARRANGER, JA ;
REUSER, AJJ ;
TAGER, JM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 134 (03) :585-589
[4]  
Barranger J. A., 1989, METABOLIC BASIS INHE, P1677
[5]   PREVALENT AND RARE MUTATIONS AMONG GAUCHER PATIENTS [J].
EYAL, N ;
WILDER, S ;
HOROWITZ, M .
GENE, 1990, 96 (02) :277-283
[6]  
FIRON N, 1990, AM J HUM GENET, V46, P527
[7]  
GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499
[8]   GAUCHER DISEASE TYPE-1 - CLONING AND CHARACTERIZATION OF A CDNA-ENCODING ACID BETA-GLUCOSIDASE FROM AN ASHKENAZI JEWISH PATIENT [J].
GRAVES, PN ;
GRABOWSKI, GA ;
EISNER, R ;
PALESE, P ;
SMITH, FI .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1988, 7 (08) :521-528
[9]   THE HUMAN GLUCOCEREBROSIDASE GENE AND PSEUDOGENE - STRUCTURE AND EVOLUTION [J].
HOROWITZ, M ;
WILDER, S ;
HOROWITZ, Z ;
REINER, O ;
GELBART, T ;
BEUTLER, E .
GENOMICS, 1989, 4 (01) :87-96
[10]  
LACERDA L, 1991, 8TH WORKSH ANN